Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12933588rdf:typepubmed:Citationlld:pubmed
pubmed-article:12933588lifeskim:mentionsumls-concept:C0596993lld:lifeskim
pubmed-article:12933588lifeskim:mentionsumls-concept:C0082978lld:lifeskim
pubmed-article:12933588lifeskim:mentionsumls-concept:C1537422lld:lifeskim
pubmed-article:12933588lifeskim:mentionsumls-concept:C1752930lld:lifeskim
pubmed-article:12933588pubmed:issue13lld:pubmed
pubmed-article:12933588pubmed:dateCreated2003-12-5lld:pubmed
pubmed-article:12933588pubmed:abstractTextInterferon consensus sequence binding protein/interferon regulatory factor 8 (ICSBP/IRF-8) is a transcription factor that controls myeloid cell development. ICSBP-/- mice develop a chronic myelogenous leukemia (CML)-like syndrome. Several observations on patients and mouse models have implicated ICSBP in the pathogenesis of CML. In this paper, we investigated whether ICSBP modulates the growth-promoting activity of Bcr/Abl, the causal oncoprotein for CML. When transformed with p210 Bcr/Abl, ICSBP-/- myeloid progenitor cells lost growth factor dependence and grew in the absence of granulocyte-macrophage colony-stimulating factor. When ICSBP was ectopically expressed, Bcr/Abl-transformed cells underwent complete growth arrest and differentiated into mature, functional macrophages without inhibiting the kinase activity of Bcr/Abl. Providing a mechanistic basis for the growth arrest, ICSBP markedly repressed c-Myc messenger RNA (mRNA)-expression, a downstream target of Bcr/Abl. A further analysis with the ICSBP/estrogen receptor chimera showed that ICSBP repression of c-Myc is indirect and is mediated by another gene(s). We identified Blimp-1 and METS/PE1, potent c-Myc repressors, as direct targets of ICSBP activated in these cells. Consistent with this, ectopic Blimp-1 repressed c-Myc expression and inhibited cell growth. These results indicate that ICSBP inhibits growth of Bcr/Abl-transformed myeloid progenitor cells by activating several genes that interfere with the c-Myc pathway.lld:pubmed
pubmed-article:12933588pubmed:languageenglld:pubmed
pubmed-article:12933588pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12933588pubmed:citationSubsetAIMlld:pubmed
pubmed-article:12933588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12933588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12933588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12933588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12933588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12933588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12933588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12933588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12933588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12933588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12933588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12933588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12933588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12933588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12933588pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12933588pubmed:statusMEDLINElld:pubmed
pubmed-article:12933588pubmed:monthDeclld:pubmed
pubmed-article:12933588pubmed:issn0006-4971lld:pubmed
pubmed-article:12933588pubmed:authorpubmed-author:OzatoKeikoKlld:pubmed
pubmed-article:12933588pubmed:authorpubmed-author:TamuraTomohik...lld:pubmed
pubmed-article:12933588pubmed:authorpubmed-author:CalameKathryn...lld:pubmed
pubmed-article:12933588pubmed:authorpubmed-author:TsujimuraHide...lld:pubmed
pubmed-article:12933588pubmed:authorpubmed-author:TunyaplinChai...lld:pubmed
pubmed-article:12933588pubmed:authorpubmed-author:KongHee...lld:pubmed
pubmed-article:12933588pubmed:issnTypePrintlld:pubmed
pubmed-article:12933588pubmed:day15lld:pubmed
pubmed-article:12933588pubmed:volume102lld:pubmed
pubmed-article:12933588pubmed:ownerNLMlld:pubmed
pubmed-article:12933588pubmed:authorsCompleteYlld:pubmed
pubmed-article:12933588pubmed:pagination4547-54lld:pubmed
pubmed-article:12933588pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12933588pubmed:meshHeadingpubmed-meshheading:12933588...lld:pubmed
pubmed-article:12933588pubmed:meshHeadingpubmed-meshheading:12933588...lld:pubmed
pubmed-article:12933588pubmed:meshHeadingpubmed-meshheading:12933588...lld:pubmed
pubmed-article:12933588pubmed:meshHeadingpubmed-meshheading:12933588...lld:pubmed
pubmed-article:12933588pubmed:meshHeadingpubmed-meshheading:12933588...lld:pubmed
pubmed-article:12933588pubmed:meshHeadingpubmed-meshheading:12933588...lld:pubmed
pubmed-article:12933588pubmed:meshHeadingpubmed-meshheading:12933588...lld:pubmed
pubmed-article:12933588pubmed:meshHeadingpubmed-meshheading:12933588...lld:pubmed
pubmed-article:12933588pubmed:meshHeadingpubmed-meshheading:12933588...lld:pubmed
pubmed-article:12933588pubmed:meshHeadingpubmed-meshheading:12933588...lld:pubmed
pubmed-article:12933588pubmed:meshHeadingpubmed-meshheading:12933588...lld:pubmed
pubmed-article:12933588pubmed:meshHeadingpubmed-meshheading:12933588...lld:pubmed
pubmed-article:12933588pubmed:meshHeadingpubmed-meshheading:12933588...lld:pubmed
pubmed-article:12933588pubmed:meshHeadingpubmed-meshheading:12933588...lld:pubmed
pubmed-article:12933588pubmed:meshHeadingpubmed-meshheading:12933588...lld:pubmed
pubmed-article:12933588pubmed:meshHeadingpubmed-meshheading:12933588...lld:pubmed
pubmed-article:12933588pubmed:meshHeadingpubmed-meshheading:12933588...lld:pubmed
pubmed-article:12933588pubmed:meshHeadingpubmed-meshheading:12933588...lld:pubmed
pubmed-article:12933588pubmed:meshHeadingpubmed-meshheading:12933588...lld:pubmed
pubmed-article:12933588pubmed:meshHeadingpubmed-meshheading:12933588...lld:pubmed
pubmed-article:12933588pubmed:meshHeadingpubmed-meshheading:12933588...lld:pubmed
pubmed-article:12933588pubmed:meshHeadingpubmed-meshheading:12933588...lld:pubmed
pubmed-article:12933588pubmed:meshHeadingpubmed-meshheading:12933588...lld:pubmed
pubmed-article:12933588pubmed:meshHeadingpubmed-meshheading:12933588...lld:pubmed
pubmed-article:12933588pubmed:year2003lld:pubmed
pubmed-article:12933588pubmed:articleTitleICSBP/IRF-8 inhibits mitogenic activity of p210 Bcr/Abl in differentiating myeloid progenitor cells.lld:pubmed
pubmed-article:12933588pubmed:affiliationBldg 6, Rm 2A01, Laboratory of Molecular Growth Regulation, National Institute of Child Health and Human Development, National Institutes of Health, 6 Center Dr MSC 2753, Bethesda, MD 20892-2753, USA.lld:pubmed
pubmed-article:12933588pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:12142entrezgene:pubmedpubmed-article:12933588lld:entrezgene
entrez-gene:13106entrezgene:pubmedpubmed-article:12933588lld:entrezgene
entrez-gene:15900entrezgene:pubmedpubmed-article:12933588lld:entrezgene
entrez-gene:17869entrezgene:pubmedpubmed-article:12933588lld:entrezgene
entrez-gene:27049entrezgene:pubmedpubmed-article:12933588lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12933588lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12933588lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12933588lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12933588lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12933588lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12933588lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12933588lld:pubmed